Vertex announces key advancements across kidney portfolio

marketscreener
2025.09.25 12:35
portai
I'm PortAI, I can summarize articles.

Sept 25 (Reuters) - Vertex Pharmaceuticals Inc:Vertex announces key advancements across kidney portfolio Vertex Pharmaceuticals Inc: FDA granted breakthrough therapy designation for povetacicept in IgA nephropathy Vertex Pharmaceuticals Inc - on track to file for accelerated approval in U.S. in H1 2026

Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer